Crocs shares slide after shoe retailer tempers full-year sales outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Crocs (CROX) PT Lowered to $138 at Stifel, 'Brand and Improving Balance Sheet Support Risk/Reward'
October 30, 2024 7:00 AM EDTStifel analyst Jim Duffy lowered the price target on Crocs (NASDAQ: CROX) to $138.00 (from $158.00) while maintaining a Buy rating.
The analyst comments "3Q24 revenue (+$16mn) and adj. EPS upside (+$0.52) benefited from a pull-forward of wholesale orders, and 4Q24 revenue and adj.... More
BNP Paribas Exane on Crocs (CROX): 'We believe results and guidance for the Crocs brand were generally in-line with expectation'
October 30, 2024 6:59 AM EDTBNP Paribas Exane analyst Aubrey Tianello reiterated a Neutral rating and $128.00 price target on Crocs (NASDAQ: CROX).
The analyst comments "What happened? CROX reported a 3Q24 beat with revs of $1.06bn (+2% y/y) vs. cons of $1.05bn and adjusted EPS of $3.60 vs. cons of $3.10. We believe results and guidance for the Crocs brand were generally in-line with expectations. However, HEYDUDE guidance was materially cut again, putting pressure on shares pre-mkt. We provide thoughts ahead of the 8:30am ET conf. call. BNPP Exane View: 1Q results beat on Crocs strength, but HEYDUDE... More
Crocs (CROX) PT Lowered to $125 at Barclays
October 29, 2024 2:36 PM EDTBarclays analyst Adrienne Yih lowered the price target on Crocs (NASDAQ: CROX) to $125.00 (from $164.00) while maintaining a Overweight rating.
The analyst comments "3Q24 results beat expectations on sales, OM, and EPS, mostly driven by SG&A leverage. Despite the... More
Crocs (CROX) PT Lowered to $140 at Williams Trading
October 29, 2024 2:21 PM EDTWilliams Trading analyst Sam Poser lowered the price target on Crocs (NASDAQ: CROX) to $140.00 (from $163.00) while maintaining a Buy rating.
The analyst comments "Lowering PT from $163 to $140, raising FY24 estimates, lowering FY25 estimates, and introducing FY26 estimates. The better than expected 3Q24 results were driven by a 7.5% increase in Crocs revenue, which beat consensus by 2.5%,... More
